Pattern of gastritis and duodenitis depending on the stage of gastroesophageal reflux disease associated with acid-related diseases


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Background. Gastroesophageal reflux disease (GERD) is considered s a global medical problem. However, the state of the gastroduodenal (GD) mucous membrane (MM) in different stages of GERD comorbid with acid-dependent pathology, as well as some GD-associated dysfunctions require clarification. Objective. Identification of the relationship between the severity of gastritis and duodenitis and the state of esophageal MM in GERD associated with another acid-related pathology, and determine additional motor-secretory disorders for targeted therapy. Methods. In 2012-2017, 305 patients with GERD and comorbid duodenal ulcer, stomach ulcer and chronic pancreatitis were examined in the settings of the Kuban State Medical University. Study design: case series. All patients underwent esophagogastroduodenoscopy with biopsy of duodenum, antrum and body of the stomach; evaluation of gastric secretion and endoscopic manometry were performed in 145 patients, histological detection of Helicobacter pylori - in 84 patients. Results. Patients with stage C comorbid GERD compared with patients with non-erosive reflux disease (NERD) had more pronounced, statistically significant (p<0.001) gastritis manifestations according to endoscopic and histological criteria, as well as higher rates of inter-digestive HCl production (p<0.001). H. pylori Infection in the stomach body MM compared with its absence was accompanied by lower rates of interdigestive HCl secretion (p<0.001). Conclusion. In patients with GERD and comorbid acid-related diseases, syntropic histopathological changes in each of the sections of the GDMM (metaplasia and atrophy) are associated with the severity of reflux esophagitis, with basal gastric acid production and an increase in GD pressure not only in GERD, but also in NERD.

Texto integral

Acesso é fechado

Sobre autores

E. Gorban

Kuban State Medical University

V. Durleshter

Kuban State Medical University

N. Korochanskaya

Kuban State Medical University

Vitaly Gorban

Kuban State Medical University

Email: gorbanvv@mai1.ru
MD, Head of the Department of Outpatient Therapy with the Course of GMP (FM) of the FATPRS

Bibliografia

  1. Маев И.В., Бурков С.Г., Юренев Г.Л. Гастроэзофагеальная рефлюксная болезнь и ассоциированная патология. М.: ГЭОТАР-Медиа, 2014. 352 с.
  2. Pique N., Ponce M., Garrigues V., et al. Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study). United Eur Gastroenterol J. 2016;4:229-35. Doi: 10.1177/ 2050640615595916. PMID: 27087951.
  3. Serag H.B., Sweet S., Winchester C.C., Dent J. Update on the epidemiology of gastro-oesophageai reflux disease: a systematic review. Gut. 2014;63:871-80. Doi: 10.1136/ gutjni-2012-304269. PMID: 23853213.
  4. Ивашкин В.Т., Маев И.В., Лапина Т.Л. и др. Лечение инфекции Helicobacter pylori: мейнстрим и новации. Российский журнал гастроэнтерологии, гепатологии и колопроктологии. 2017;27(4):4-21.
  5. Kim S.W., LeeJ. H., Sim YS, et al. Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease. Korean J Intern Med. 2014;29:466-73. Doi: 10.3904/ kjim.2014.29.4.466.
  6. Lee S.W., Lee T.Y, Lien H.C., et al. Characteristics of symptom presentation and risk factors in patients with erosive esophagitis and nonerosive reflux disease. Med Princ Pract. 2014;23:460-64. doi: 10.1159/000363661.
  7. Mochizuki N., Fujita T., Kobayashi M., et al. Factors associated with the presentation of erosiveesophagitis symptoms in health checkup subjects: A prospective, multicenter cohort study. PLoS ONE. 2018;13(5):e0196848. doi: 10.1371/journal. pone.0196848.
  8. Lei W.Y., Yu H.C., Wen S.H., et al. Predictive factors of silent reflux in subjects with erosive esophagitis. Dig Liver Dis. 2015;47:24-29. Doi: 10.1016/j. dld.2014.09.017. PMID: 25308612.
  9. Choi J.Y., Jung H.K., Song E.M., et al. Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease. Eur J. Gastroenterol Hepatol. 2013;25:764-71. Doi: 10.1097/ MEG.0b013e32835f594c PMID: 23459104.
  10. Grande M., Lisi G., De Sanctis F., et al. Does a relationship still exist between gastroesophageal reflux and Helicobacter pylori in patients with reflux symptoms? World J. SurgOncol. 2014,12:375. doi: 10.1186/1477-7819-12-375.
  11. Ashktorab H., Entezari O., Nouraie M., et al. Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci. 2012;57:2924-28. doi: 10.1007/s10620-012-2349-3.
  12. Yaghoobi M., Farrokhyar F., Yuan Y., Hunt R.H. Is there an increased risk of GERD after Helicobacter pylori eradication? a meta-analysis. Am J. Gastroenterol. 2010;105:1007-13. Doi: 10.1038/ ajg.2009.734.
  13. Лазебник Л.Б., Конев Ю.В. Исторические особенности и семантические трудности использования терминов, обозначающих множественность заболеваний у одного больного. Экспериментальная и клиническая гастроэнтерология. 2018;154(6):74-9.
  14. Chung S.H., Lee K.J., Kim J.Y., et al. Association of the Extent of Atrophic Gastritis With Specific Dyspeptic Symptoms. J. Neurogastroenterol Motil. 2015;21(4):21:528-36. Doi: 10.5056/ jnm15074.
  15. Yamamichi N., Mochizuki S., Asada-Hirayama I., et al. Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores. BMC Med. 2012;10:45. doi: 10.1186/1741-7015-10-45.
  16. Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J. Gastroenterol. 2006;41:95-99.
  17. Nobakht H., Boghratian A., Sohrabi M., et al. Association between Pattern of Gastritis and Gastroesophageal Reflux Disease in Patients with Helicobacter Pylori Infection. Middle East J. Dig Dis. 2016;8(3):206-11. Doi: 10.15171/ mejdd.2016.33.
  18. Pasechnikov V.D., Chotchaeva A.R., Pasechnikov D.V. Effect of HP eradication on the development of gastroesophageal reflux disease: results of the prospective study. Eksp Clin Gastroenterol. 2011;3:105-10.
  19. Saad A.M., Choudhary A., Bechtold M.L. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): metaanalysis of randomized controlled trials. Scand J. Gastroenterol. 2012;47:129-35. doi: 10.3109/00365521.2011.648955.
  20. Blondeau K., Sifrim D., Gardner J.D. Continuous distal oesophageal acidification decreases postprandial gastric acidity in healthy human subjects. Aliment Pharmacol Ther. 2009; 29:561-70.
  21. Lu L., Mu J.C., Sloan S., et al. Exploring the physiologic role of human gastroesophageal reflux by analyzing time-series data from 24-h gastric and esophageal pH recordings. Physiol Rep. 2014;2(7):e12051. Doi: 10.14814/ phy2.12051.
  22. Iijima K., Ara N., Abe Y., et al. Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy. J. Gastroenterol. 2011;46:612-19.
  23. Mukaisho K., Hagiwara T., Nakayama T., et al. Potential mechanism of corpus predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD. World J. Gastroenterol. 2014;20:11962-65. doi: 10.3748/wjg.v20. i34.11962.
  24. Kawai T., Moriyasu F., Tsuchida A. Key Issues Associated with Helicobacter pylori Eradication. Digestion. 2016;93:19-23. doi: 10.1159/000441667.
  25. Kodama M., Murakami K., Okimoto T., et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J. Gastroenterol. 2012;47:394-403.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2019